Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial
J. Clin. Oncol 2020 Jun 25;[EPub Ahead of Print], MC Kreissl, L Bastholt, R Elisei, R Haddad, O Hauch, B Jarząb, B Robinson, R Colzani, M Foster, R Weiss, M SchlumbergerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.